Articles with keyword пембролизумаб

SYSTEMIC THERAPY FOR ADVANCED KIDNEY CANCER (I.V. Timofeev)

metastatic renal cell carcinoma, systemic therapy, nivolumab, ipilimumab, avelumab, axitinib, pembrolizumab, PD-L1 expression, cytoreductive nephrectomy.

Efficacy of immune checkpoints inhibitors in the treatment of solid tumors (A.A. Rumyantsev, S.A. Tjulandin)

drug therapy, immunotherapy, CTLA-4, PD-1, PD-L1, check-points, programmed cell death protein, nivolumab, pembrolizumab, ipilimumab, atezolizumab, biomarkers, efficacy